This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Mottet N, Bastian PJ, Bellmunt J, Van den Bergh RCN, Bolla M, Van Casteren NJ, et al. Guidelines on prostate cancer. Arnhem: European Association of Urology; 2014.MottetNBastianPJBellmuntJVan den BerghRCNBollaMVan CasterenNJet alGuidelines on prostate cancer.ArnhemEuropean Association of Urology2014Search in Google Scholar
Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, et al. Comparative analysis of prostate specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 2012; (109 Suppl 1): 22-9.GrimmPBillietIBostwickDDickerAPFrankSImmerzeelJet alComparative analysis of prostate specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupBJU Int2012109Suppl 122910.1111/j.1464-410X.2011.10827.x22239226Search in Google Scholar
Hoskin PJ, Rojas AM, Bownes PJ, Lowe GJ, Ostler PJ, Bryant L. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. Radiother Oncol 2012; 103: 217-22.HoskinPJRojasAMBownesPJLoweGJOstlerPJBryantL.Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancerRadiother Oncol20121032172210.1016/j.radonc.2012.01.00722341794Search in Google Scholar
Khor R, Duchesne G, Tai KH, Foroudi F, Chander S, Van Dyk S, et al. Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer. Int J Radiat Biol Phys 2012; 85: 679-85.KhorRDuchesneGTaiKHForoudiFChanderSVan DykSet al.Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancerInt J Radiat Biol Phys2012856798510.1016/j.ijrobp.2012.07.00622954770Search in Google Scholar
Pieters BR, de Back DZ, Koning CC, Zwinderman AH. Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review. Radiother Oncol 2009; 93: 168-173.PietersBRde BackDZKoningCCZwindermanAH.Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic reviewRadiother Oncol20099316817310.1016/j.radonc.2009.08.03319748692Search in Google Scholar
Lepor H. Prevention and management of complications associated with open radical retropubic prostatectomy. In: Kirby RS, Partin AW, Feneley M, Parsons JK, editors. Prostate cancer principles and practice. London: Taylor & Francis; 2006 p. 789-97.LeporH.Prevention and management of complications associated with open radical retropubic prostatectomyKirbyRSPartinAWFeneleyMParsonsJKProstate cancer principles and practiceLondonTaylor & Francis200678997Search in Google Scholar
Cesaretti JA, Stone NN, Kao J. Brachytherapy for the treatment of prostate cancer. In: Kirby RS, Partin AW, Feneley M, Parsons JK, editors. Prostate cancer principles and practice. London: Taylor & Francis; 2006. p. 817-29.CesarettiJAStoneNNKaoJBrachytherapy for the treatment of prostate cancerKirbyRSPartinAWFeneleyMParsonsJKProstate cancer principles and practiceLondonTaylor & Francis200681722910.1097/PPO.0b013e318156dcbe17921729Search in Google Scholar
Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR, CaPSURE Investigators. Incidence of urethral stricture after primary treatment for prostate cancer. J Urol 2007; 178: 529-34.ElliottSPMengMVElkinEPMcAninchJWDuchaneJCarrollPRCaPSURE Investigators. Incidence of urethral stricture after primary treatment for prostate cancerJ Urol20071785293410.1016/j.juro.2007.03.12617570425Search in Google Scholar
Deger S, Boehmer D, Roigas J, Schink T, Wernecke KD, Wiegel T, et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur Urol 2005; 47: 441-8.DegerSBoehmerDRoigasJSchinkTWerneckeKDWiegelTet alHigh dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancerEur Urol200547441810.1016/j.eururo.2004.11.01415774239Search in Google Scholar
Vargas CE, Martinez AA, Boike TP, Spencer W, Goldstein N, Gustafson GS, et al. High-dose irradiation for prostate cancer via a high-dose-rate brachy-therapy boost: results of a phase I to II study. Int J Radiat Biol Phys 2006; 66: 416-23.VargasCEMartinezAABoikeTPSpencerWGoldsteinNGustafsonGSet alHigh-dose irradiation for prostate cancer via a high-dose-rate brachy-therapy boost: results of a phase I to II studyInt J Radiat Biol Phys2006664162310.1016/j.ijrobp.2006.04.04516879929Search in Google Scholar
Yamada Y, Bhatia S, Zaider M, Cohen G, Donat M, Eastham J, et al. Favorable clinical outcomes of three dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 2006; 5: 157-64.YamadaYBhatiaSZaiderMCohenGDonatMEasthamJet alFavorable clinical outcomes of three dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancerBrachytherapy200651576410.1016/j.brachy.2006.03.00416864067Search in Google Scholar
Demanes DJ, Rodriguez RR, Schour L, Brandt D, Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy’s 10-year results. Int J Radiat Biol Phys 2005; 61: 1306-16.DemanesDJRodriguezRRSchourLBrandtDAltieriG.High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy’s 10-year resultsInt J Radiat Biol Phys20056113061610.1016/j.ijrobp.2004.08.01415817332Search in Google Scholar
Hindson BR, Millar JL, Matheson B. Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors. Brachytherapy 2013; 12: 50-5.HindsonBRMillarJLMathesonB.Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factorsBrachytherapy20131250510.1016/j.brachy.2012.03.004Search in Google Scholar
Martínez-Monge R, Moreno M, Ciérvide R, Cambeiro M, Pérez-Gracia JL, Gil-Bazo I, et al. External-beam radiation therapy and high-dose-rate brachy-therapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: preliminary data on clinical outcome. Int J Radiat Biol Phys 2012; 82: 469-76.Martínez-MongeRMorenoMCiérvideRCambeiroMPérez-GraciaJLGil-BazoIet alExternal-beam radiation therapy and high-dose-rate brachy-therapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: preliminary data on clinical outcomeInt J Radiat Biol Phys2012824697610.1016/j.ijrobp.2011.08.002Search in Google Scholar
Sullivan L, Williams SG, Tai KH, Foroudi F, Cleeve L, Duchesne GM. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol 2009; 91: 232-6.SullivanLWilliamsSGTaiKHForoudiFCleeveLDuchesneGM.Urethral stricture following high dose rate brachytherapy for prostate cancerRadiother Oncol200991232610.1016/j.radonc.2008.11.013Search in Google Scholar
Galalae RM, Kovács G, Schultze J, Loch T, Rzehak P, Wilhelm R, et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Biol Phys 2002; 52: 81-90.GalalaeRMKovácsGSchultzeJLochTRzehakPWilhelmRet alLong-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancerInt J Radiat Biol Phys200252819010.1016/S0360-3016(01)01758-8Search in Google Scholar
Yamada Y, Rogers L, Demanes DJ, Morton G, Prestidge BR, Pouliot J, et al. American brachytherapy society consensus guidlines for high-dose-rate prostate brachytherapy. Brachytheapy 2012; 11: 20-32.YamadaYRogersLDemanesDJMortonGPrestidgeBRPouliotJet al.American brachytherapy society consensus guidlines for high-dose-rate prostate brachytherapyBrachytheapy201211203210.1016/j.brachy.2011.09.008Search in Google Scholar
Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Allen ZA, et al. Risk factors for the development of prostate brachytherapy related urethral strictures. J Urol 2006; 175: 1376-81.MerrickGSButlerWMWallnerKEGalbreathRWAndersonRLAllenZAet al.Risk factors for the development of prostate brachytherapy related urethral stricturesJ Urol200617513768110.1016/S0022-5347(05)00681-6Search in Google Scholar
Parihar JS, Ha YS, Kim IY. Bladder neck contracture-incidence and management following contemporary robot assisted radical prostatectomy. Prostate Int 2014; 1: 12-8.PariharJSHaYSKimIY.Bladder neck contracture-incidence and management following contemporary robot assisted radical prostatectomyProstate Int2014112810.12954/PI.13034397098424693529Search in Google Scholar
Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int 2010; 106: 1734-8.BreyerBNDavisCBCowanJEKaneCJCarrollPR.Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomyBJU Int20101061734810.1111/j.1464-410X.2010.09333.x356560820438567Search in Google Scholar
D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74.D’AmicoAVWhittingtonRMalkowiczSBSchultzDBlankKBroderickGAet al.A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancerJAMA19982809697410.1001/jama.280.11.9699749478Search in Google Scholar
Grabec D, Kragelj B. The sigmoid colon and bladder shielding in whole pelvic irradiation at prostate cancer (forward planned IMRT from Institute of oncology Ljubljana). Radiol Oncol 2009; 43: 56-64.GrabecDKrageljB.The sigmoid colon and bladder shielding in whole pelvic irradiation at prostate cancer (forward planned IMRT from Institute of oncology Ljubljana)Radiol Oncol200943566410.2478/v10019-009-0001-4Search in Google Scholar
Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1994; 28: 33-7.RoachM3rdMarquezCYuoHSNarayanPColemanLNseyoUOet al.Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancerInt J Radiat Oncol Biol Phys19942833710.1016/0360-3016(94)90138-4Search in Google Scholar
Cox JD, Stetz JA, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Biol Phys 1995; 31: 1341-6.CoxJDStetzJAPajakTF.Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)Int J Radiat Biol Phys1995311341610.1016/0360-3016(95)00060-CSearch in Google Scholar
Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Biol Phys 1995; 31: 1257-80.MarksLBCarrollPRDuganTCAnscherMS.The response of the urinary bladder, urethra, and ureter to radiation and chemotherapyInt J Radiat Biol Phys19953112578010.1016/0360-3016(94)00431-JSearch in Google Scholar
Hosmer DW, Lemeshow S. Applied logistic regression. New York (NY): John Wiley & Sons; 2000.HosmerDWLemeshowSApplied logistic regression.New York (NY)John Wiley & Sons200010.1002/0471722146Search in Google Scholar
McNeil BJ, Keeler E, Adelstein JS. Primer on certain elements of medical decision making. N Engl J Med 1975; 293: 211-215.McNeilBJKeelerEAdelsteinJS.Primer on certain elements of medical decision makingN Engl J Med197529321121510.1056/NEJM197507312930501806804Search in Google Scholar
Bradley GW, editor. Disease, diagnosis and decisions. Chichester: John Wiley & Sons; 1993.BradleyGWDisease, diagnosis and decisionsChichesterJohn Wiley & Sons1993Search in Google Scholar
Kallin Westin L. Receiver operating characteristic (ROC) analysis: valuating discriminance effects among decision support systems. Umea: Umea University, Department of Computing Science; 2001.KallinWestin LReceiver operating characteristic (ROC) analysis: valuating discriminance effects among decision support systemsUmeaUmea University, Department of Computing Science2001Search in Google Scholar
Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology 2005; 16: 73-81.SchistermanEFPerkinsNJLiuABondellH.Optimal cut-point and corresponding Youden index to discriminate individuals using pooled blood samplesEpidemiology200516738110.1097/01.ede.0000147512.81966.ba15613948Search in Google Scholar
Mathieu R, Arango JD, Beckendorf V, Delobel JB, Messai T, Chira C, et al. Nomograms to predict late urinary toxicity after prostate cancer radiotherapy. World J Urol 2014; 32: 743-51.MathieuRArangoJDBeckendorfVDelobelJBMessaiTChiraCet al.Nomograms to predict late urinary toxicity after prostate cancer radiotherapyWorld J Urol20143274351Search in Google Scholar
Hsu IC, Hunt D, Straube W, Pouliot J, Cunha A, Krishnamurthy D, et al. Dosimetric analysis of radiation therapy oncology group 0321: The importance of urethral dose. Pract Radiat Oncol 2014; 4: 27-34.HsuICHuntDStraubeWPouliotJCunhaAKrishnamurthyDet al.Dosimetric analysis of radiation therapy oncology group 0321: The importance of urethral dosePract Radiat Oncol20144273410.1016/j.prro.2013.02.011400055024621420Search in Google Scholar
McLaughlin PW, Narayana V. High-dose-rate strictures: A theory of cancer meets anatomic reality. Brachytherapy 2013; 12: 199-201.McLaughlinPWNarayanaV.High-dose-rate strictures: A theory of cancer meets anatomic realityBrachytherapy20131219920110.1016/j.brachy.2013.03.00123541480Search in Google Scholar
Ishiyama H, Kitano M, Satoh T, Kotani S, Uemae M, Matsumoto K, et al. Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity. Int J Radiat Biol Phys 2009; 75: 23-8.IshiyamaHKitanoMSatohTKotaniSUemaeMMatsumotoKet al.Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicityInt J Radiat Biol Phys20097523810.1016/j.ijrobp.2008.11.00619243900Search in Google Scholar
Ghadjar P, Rentsch CA, Isaak B, Behrensmeier F, Thalmann GN, Aebersold DM. Urethral toxicity vs. cancer control – lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate-and high-risk prostate cancer. Brachytherapy 2011; 11: 286-94.GhadjarPRentschCAIsaakBBehrensmeierFThalmannGNAebersoldDM.Urethral toxicity vs. cancer control – lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate-and high-risk prostate cancerBrachytherapy2011112869410.1016/j.brachy.2010.09.00521030318Search in Google Scholar
Pellizzon ACA, Salvajoli JV, Maia MAC, Ferrigno R, Dos Santos Novaes PER, Fogarolli RC, et al. Late urinary morbidity with high dose prostate brachy-therapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. J Urol 2004; 171: 1105-8.PellizzonACASalvajoliJVMaiaMACFerrignoRDos Santos NovaesPERFogarolliRCet al.Late urinary morbidity with high dose prostate brachy-therapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancerJ Urol20041711105810.1097/01.ju.0000113260.07979.d314767280Search in Google Scholar
Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Eble MJ. Low-grade toxicity after conformal radiation therapy for prostate cancer-impact of bladder volume. Int J Radiat Biol Phys 2006; 64: 835-41.PinkawaMFischedickKAsadpourBGagelBPirothMDEbleMJ.Low-grade toxicity after conformal radiation therapy for prostate cancer-impact of bladder volumeInt J Radiat Biol Phys2006648354110.1016/j.ijrobp.2005.09.00316289911Search in Google Scholar
Ali AN, Rossi PJ, Godette KD, Martin D, Liauw S, Vijayakumar S, et al. Impact of magnetic resonance imaging on computed tomography –based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy. Pract Radiat Oncol 2013; 3: e1-9.AliANRossiPJGodetteKDMartinDLiauwSVijayakumarSet al.Impact of magnetic resonance imaging on computed tomography –based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapyPract Radiat Oncol20133e1910.1016/j.prro.2012.04.00524674267Search in Google Scholar
